Related references
Note: Only part of the references are listed.Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma
Eudocia Q. Lee et al.
CLINICAL CANCER RESEARCH (2018)
Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
Amnon Peled et al.
CYTOKINE (2018)
Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar
Vashendriya V. V. Hira et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
Viktor Fleming et al.
FRONTIERS IN IMMUNOLOGY (2018)
The combination of CXCR4 and checkpoint receptor inhibition improves survival in an orthotopic murine glioma model
Adela Wu et al.
CANCER RESEARCH (2018)
CXCR4 blockade at the end of irradiation to improve local control of glioblastoma (GBM).
Reena Parada Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Human glioblastoma arises from subventricular zone cells with low-level driver mutations
Joo Ho Lee et al.
NATURE (2018)
Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity
Gianluca D'Agostino et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment
Katharina Helene Susek et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis
Tyler J. Alban et al.
JCI INSIGHT (2018)
The unique structural and functional features of CXCL12
Rik Janssens et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy
Naz Chaudary et al.
CLINICAL CANCER RESEARCH (2017)
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
Haley Gittleman et al.
NEURO-ONCOLOGY (2017)
CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone
Nicolas Goffart et al.
NEURO-ONCOLOGY (2017)
Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
Y. Deng et al.
ONCOGENE (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline
Erik P. Sulman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study
H. Ludwig et al.
LEUKEMIA (2017)
ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial
Ulrich Herrlinger et al.
NEURO-ONCOLOGY (2017)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI
Lei Deng et al.
NEOPLASIA (2017)
The Role of Hypoxia in Glioblastoma Invasion
Ana Rita Monteiro et al.
CELLS (2017)
Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection
Carsten Herskind et al.
FRONTIERS IN ONCOLOGY (2017)
Mechanisms regulating radiosensitivity of glioma stem cells
Y. Liu et al.
NEOPLASMA (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
The Promise of Targeting Macrophages in Cancer Therapy
J. Martin Brown et al.
CLINICAL CANCER RESEARCH (2017)
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
Daniel Dubinski et al.
NEURO-ONCOLOGY (2016)
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma
Federica Barbieri et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Atypical chemokine receptors in cancer: friends or foes?
Matteo Massara et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Robert Eil et al.
NATURE (2016)
Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
Wen-Juan Huang et al.
ONCOLOGY LETTERS (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
BK K+ channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells
Lena Edalat et al.
ONCOTARGET (2016)
Estrogen-induced SDF-1α production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment
Liquan Ouyang et al.
SCIENTIFIC REPORTS (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine et al.
SCIENCE IMMUNOLOGY (2016)
CXCL12 Signaling Is Essential for Maturation of the Ventricular Coronary Endothelial Plexus and Establishment of Functional Coronary Circulation
Susana Cavallero et al.
DEVELOPMENTAL CELL (2015)
The CXCL12/CXCR4 Axis Plays a Critical Role in Coronary Artery Development
Sarah Ivins et al.
DEVELOPMENTAL CELL (2015)
SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis
Patricia Dillenburg-Pilla et al.
FASEB JOURNAL (2015)
CXCR4 Inhibition in Tumor Microenvironment Facilitates Anti-Programmed Death Receptor-1 Immunotherapy in Sorafenib-Treated Hepatocellular Carcinoma in Mice
Yunching Chen et al.
HEPATOLOGY (2015)
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Concepts of immunotherapy for glioma
Mira A. Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue
Paul R. Gielen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
Michele Cioffi et al.
SCIENTIFIC REPORTS (2015)
Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives
Lukas Pawig et al.
FRONTIERS IN IMMUNOLOGY (2015)
Paving the road to tumor development and spreading: myeloid-derived suppressor cells are ruling the fate
Yaron Meirow et al.
FRONTIERS IN IMMUNOLOGY (2015)
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel et al.
BLOOD (2014)
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats
M. J. Walters et al.
BRITISH JOURNAL OF CANCER (2014)
Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy
J. M. Brown
BRITISH JOURNAL OF RADIOLOGY (2014)
The Disparate Twins: A Comparative Study of CXCR4 and CXCR7 in SDF-1α-Induced Gene Expression, Invasion and Chemosensitivity of Colon Cancer
Doreen Heckmann et al.
CLINICAL CANCER RESEARCH (2014)
Differential Effects of Sorafenib on Liver Versus Tumor Fibrosis Mediated by Stromal-Derived Factor 1 Alpha/C-X-C Receptor Type 4 Axis and Myeloid Differentiation Antigen-Positive Myeloid Cell Infiltration in Mice
Yunching Chen et al.
HEPATOLOGY (2014)
Is Indirect Cell Death Involved in Response of Tumors to Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy?
Chang W. Song et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
So Hyun Bae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats
Shie-Chau Liu et al.
NEURO-ONCOLOGY (2014)
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
Roberto Wuerth et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems
Alice Guyon
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy
F. -W. Kreth et al.
ANNALS OF ONCOLOGY (2013)
Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
Sameer Agnihotri et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment
Alina Filatova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Dynamic Mast Cell-Stromal Cell Interactions Promote Growth of Pancreatic Cancer
Ying Ma et al.
CANCER RESEARCH (2013)
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Lin Cheng et al.
CELL (2013)
Peripheral Nerve-Derived CXCL12 and VEGF-A Regulate the Patterning of Arterial Vessel Branching in Developing Limb Skin
Wenling Li et al.
DEVELOPMENTAL CELL (2013)
Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation
Moshe Sade-Feldman et al.
IMMUNITY (2013)
Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line
Meng Wang et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
HMGB1 and leukocyte migration during trauma and sterile inflammation
Emilie Venereau et al.
MOLECULAR IMMUNOLOGY (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
M-J Jung et al.
ONCOGENE (2013)
Radiation Therapy-Induced Tumor Invasiveness Is Associated with SDF-1-Regulated Macrophage Mobilization and Vasculogenesis
Shu-Chi Wang et al.
PLOS ONE (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Paola Filipazzi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
Sadhak Sengupta et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
The presumed atypical chemokine receptor CXCR7 signals through Gi/o proteins in primary rodent astrocytes and human glioma cells
Veysel Oedemis et al.
GLIA (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
The IKKα-Dependent NF-κB p52/RelB Noncanonical Pathway Is Essential To Sustain a CXCL12 Autocrine Loop in Cells Migrating in Response to HMGB1
Richard R. Kew et al.
JOURNAL OF IMMUNOLOGY (2012)
In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer
Duha Fahham et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmstrom et al.
LANCET ONCOLOGY (2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Wolfgang Wick et al.
LANCET ONCOLOGY (2012)
Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities
Martin Klein
NEURO-ONCOLOGY (2012)
CXCL12 Mediates Trophic Interactions between Endothelial and Tumor Cells in Glioblastoma
Shyam Rao et al.
PLOS ONE (2012)
New insights into chronic inflammation-induced immunosuppression
Julia Kanterman et al.
SEMINARS IN CANCER BIOLOGY (2012)
Perivascular mesenchymal stem cells in the adult human brain: a future target for neuroregeneration?
Ilknur Ozen et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas
D. Tseng et al.
BRITISH JOURNAL OF CANCER (2011)
Signal Transduction Inhibitors and Antiangiogenic Therapies for Malignant Glioma
Ingo K. Mellinghoff et al.
GLIA (2011)
Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study
John F. de Groot et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
Baisakhi Raychaudhuri et al.
NEURO-ONCOLOGY (2011)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity
Miriam Sciaccaluga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S. Singh et al.
BRITISH JOURNAL OF CANCER (2010)
The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
Kirsten Hattermann et al.
CANCER RESEARCH (2010)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2010)
Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas
Jeffrey P. Greenfield et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings
Karen Hilverda et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer (vol 155, pg 231, 2009)
Eugene H. Huang et al.
JOURNAL OF SURGICAL RESEARCH (2010)
CXCR4 mediates the proliferation of glioblastoma progenitor cells
Moneeb Ehtesham et al.
CANCER LETTERS (2009)
The CXCL12 (SDF-1)/CXCR4 Axis Is Essential for the Development of Renal Vasculature
Yoshitsugu Takabatake et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Effects of CXCR4 Antagonist CTCE-9908 on Prostate Tumor Growth
Stacy Porvasnik et al.
PROSTATE (2009)
The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis
Meizhang Li et al.
SEMINARS IN CANCER BIOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
Eugene H. Huang et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1α/CXCR4 expression in glioblastomas -: One plausible explanation of Scherer's structures
David Zagzag et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
Yasushi Sawanobori et al.
BLOOD (2008)
Hypoxia-inducible factor (HIF)-1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)
Zhi-Bo Han et al.
CARCINOGENESIS (2008)
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
Zhenhua Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival
Xiu-Wu Bian et al.
NEUROSURGERY (2007)
The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis
Isabelle Petit et al.
TRENDS IN IMMUNOLOGY (2007)
Nestin, PDGFRβ, CXCL12 and VEGF in glioma patients -: Different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information
Ernanuela Maderna et al.
CANCER BIOLOGY & THERAPY (2007)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Niche-to-niche migration of bone-marrow-derived cells
Rosandra N. Kaplan et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Cognitive functions in brain tumor patients
Denise D. Correa
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2006)
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Jennifer M. Burns et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea
TC Jang et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
'Pseudopalisading' necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis
Yuan Rong et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
A multicentre prospective collection of newly diagnosed glioblastoma patients in Lombardia, Italy
A Salmaggi et al.
NEUROLOGICAL SCIENCES (2005)
CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: A single-institution study in 50 patients
A Salmaggi et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Stromal cell-derived factor-1α (SDF-lα/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation
C Porcile et al.
EXPERIMENTAL CELL RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo
YX Sun et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
CXCR4 regulates growth of both primary and metastatic breast cancer
MCP Smith et al.
CANCER RESEARCH (2004)
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
M Darash-Yahana et al.
FASEB JOURNAL (2004)
Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1
BD Kelly et al.
CIRCULATION RESEARCH (2003)
RANTES: a versatile and controversial chemokine
V Appay et al.
TRENDS IN IMMUNOLOGY (2001)
Share Paper
